Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Lewy Body Disease · Parkinson Disease Dementia · Dementia With Lewy Bodies
Bottom Line
View on ClinicalTrials.gov: NCT04649164 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Peer mentor support and caregiver intervention (Behavioral); Focus group to provide feedback on educational materials and mentoring program (Other)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Rush University Medical Center
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mastery Scale |
21.65; 18.91; 22.13; 19.2 | 0.36 |
| SECONDARY Loneliness Scale |
5.64; 5.71 | — |
| SECONDARY Short Zarit Burden Interview (ZBI-12) |
23.18; 22.18 | 0.30 |
| SECONDARY Hospital Anxiety and Depression Scale (HADS) - Anxiety Score |
9.5; 8.79 | 0.1 |
| SECONDARY Geriatric Depression Scale - Short Form (GDS-SF) |
5.0; 4.22 | 0.04 sig |
| SECONDARY Dementia Attitudes Scale (DAS) |
120.97; 104.25; 121.60; 111.57 | — |
| SECONDARY Duration of Mentoring Calls |
45.04 | — |
| SECONDARY Hospital Anxiety and Depression Scale - Depression Score |
6.32; 5.61 | 0.13 |
Summary
Eligibility Criteria
Inclusion Criteria
- Focus group participants
- Each subject must be 21 years of age or older. A subject may identify as any sex, any race, and any ethnicity.
- Subjects must be either:
i. Individuals who served as peer mentors in our previous study of caregiver peer mentoring and completed at least 16 weeks of mentoring. ii. Individuals who were caregiver mentees in our previous study of caregiver peer mentoring who completed 16 weeks of mentoring. iii. Current informal family caregivers of community-dwelling LBD patients in the Chicago area, recruited from Rush University System for Health and Advocate Aurora Health, who have not participated in mentoring. c. Each subject must be primarily English-speaking. d. Each subject must be willing and able to attend a virtual, online focus group via an internet- and video-camera-equipped computer, tablet, or smartphone.
- Peer mentors
- Each subject must be 21 years of age or older. A subject may identify as any sex, any race, and any ethnicity.
- Each subject must be a non-professional caregiver (defined as cohabitating with or spending >10 hours weekly on unpaid caregiving duties) of LBD patients. Mentors may participate regardless of their loved one's status (living at home, institutionalized, or deceased).
i. If mentors also receive compensation for a portion of their time spent on caregiving duties through state or community programs, they may participate as long as they cohabitate or spend >10 hours providing unpaid care to their loved one. c. Each subject must have >2 years of LBD caregiving experience d. Each subject must be primarily English-speaking. e. Each subject must have a working email address and internet access. f. Each subject must have a working telephone number at which he or she can be reached and which he or she is willing to share with the matched mentee.
g. Each subject who will attend an online peer mentor training session must have an internet- and video-camera-equipped computer, tablet, or smartphone
- Caregiver mentees
- Each subject must be 21 years of age or older. A subject may identify as any sex, any race, and any ethnicity.
- Each subject must be a non-professional, unpaid caregiver, as defined above, of a community-dwelling LBD patient.
- Each subject must be interested in improving their caregiving mastery.
- Each subject must be primarily English-speaking.
- Each subject must have a working email address and internet access.
- Each subject must have a working telephone number at which he or she can be reached and which he or she is willing to share with the matched mentor.
Exclusion Criteria
- Subjects exhibiting symptoms of a severe psychiatric disorder interfering with their ability to participate in the study, as determined by a study team member or the PI.
- Subjects who are primarily non-English-speaking.
- Terminal illness (life expectancy of < 12 months).
Data sourced from ClinicalTrials.gov (NCT04649164). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.